Antidepressant discontinuation patterns and characteristics across sociodemographic groups in the United States

While antidepressants are frequently used, less is known about contemporary discontinuation patterns, especially across different sociodemographic populations. Patients 16–84 years initiating antidepressants between 2016 and 2019 within a large US health insurer were identified. The association between patient characteristics and time until antidepressant discontinuation was evaluated using adjusted Cox proportional hazard regression. Across 1,365,576 patients, mean time to discontinuation was 168.1 days (SD: 223.6). Men were more likely to discontinue than women (HR: 0.94, 95%CI: 0.94–0.94). Younger patients (16–24 years) were more likely to discontinue than older patients. Patients who were non-White (Asian HR: 1.33, 95%CI: 1.31–1.34; Black HR: 1.27, 95%CI: 1.27–1.28; Hispanic HR: 1.34, 95%:CI 1.34–1.35), with evidence of a substance use disorder (HR: 1.31, 95%CI: 1.27–1.35), or taking tricyclic antidepressants (HR:1.26, 95%CI: 1.25–1.27) were more likely to discontinue. Information on reasons for discontinuation was not available, and wide standard deviations for the primary outcome were reported. The results may not be generalized to non-commercially insured beneficiaries. Discontinuation is common within the first 6 months of treatment but varies across populations, highlighting patients who may benefit from potential intervention. •Most patients discontinued their antidepressants around 6 months post-initiation.•Discontinuation patterns varied across different patient characteristics.•Younger, male, non-White race patients were more likely to discontinue.•Patients with certain diagnoses and drugs were more likely to discontinue.